A recent study investigated the effects of GLP-1R agonists in a multi-hit mouse model in which the combination of a high-fat diet and angiotensin II-induced a cardiometabolic HFpEF phenotype that resembles the human HFpEF phenotype to a large extent characterized by obesity, impaired glucose handling, and metabolic dysregulation accompanied by inflammation
Initiation of viral RNA-dependent RNA polymerization
S.GhoshP.GhuleA
Patients often explore this as part of a structured plan that includes nutrition, activity, and clinical oversight
Culturally, GLP-1s are accelerating a reframing of weight as a biological and systemic issue rather than a moral one
its totally fine. Its not fine, and so we have to be willing to recognize that weve been at fault, and we can do better if were only willing to. Fatima Cody Stanford, MD, MPH, MPA, associate professor of medicine and pediatrics, Harvard Medical School